RespireRx Pharmaceuticals Inc (fka RSPI)

[bigtalan]

I took your key points and asked would it be included or addressed

Hello

Is what listed below be in your update you were hoping to get out in June . I think this hit what investor and future ones would love to hear about thank you

It would be nice if the next update they were at a point where they could start building out the narrative towards re-engaging the public markets.

-Progress in KRM-ll-81 IND-enabling "de-risking" approaching 1 year now into a 2-yr grant.
-Update on CX-717/1739 advancements with either DOD SCI grant or the ADHD grant they applied for
-Both CNS platforms: what are the next hurdles and milestones?
-Resource buildout: People & Partnerships; strategy to keep pushing forward
-Capital raising efforts via Castle; update on interest and triggering activities needed to bring capital on board
-Filings, Form 10, etc. Anticipated process and timelines..
-Presentation strategies; (which probably should be initiated before they begin to re-engage public markets and drive interest)

It is only logical to me that they would want to be re-engaged and trading with public markets well before submitting the IND in order the capitalize on that and the sequence of catalysts that follow. This entire process needs to be confidently smooth. Meaning leave no questions in the minds of all stakeholders and future investors so everyone understands the opportunity and expected milestones and timelines and really how stakeholders fit in the equation.

Answer Yes to all of those items.

Followup sounds great is June looking like it will happen

Answer Yes

GLTA